Nevertheless, it is not likely that glial NK1R are essentially involved in migraine pain as targeting NK1R as an acute and/or preventative therapeutic approach for migraine failed in human trials, probably due to the fact that substance P and NK1R expression is lower in humans compared to rodents [81]. The gene discussed is TAC1; the disease is migraine disorder.